Q1WB
ROIV icon

Quest 10 Wealth Builders’s Roivant Sciences ROIV Stock Holding History

Quest 10 Wealth Builders’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-858
Closed -$9.67K – 904
2025
Q2 		$9.67K Hold
858
– – 0.01% 405
2025
Q1 		$8.66K Hold
858
– – 0.01% 382
2024
Q4 		$10.2K Buy
+858
New +$10.1K 0.01% 392

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return

Quest 10 Wealth Builders's ROIV Position: Q3 2025 in Review

Quest 10 Wealth Builders sold out of Roivant Sciences (ROIV) in Q3 2025, closing a stake of 858 shares — an estimated $9.67K sold.

Quest 10 Wealth Builders first reported a position in ROIV in Q4 2024 and held it in 3 quarters. The position peaked at $10.2K in Q4 2024. 337 funds tracked by Wall St. Rank hold ROIV as of Q3 2025.

  • Quest 10 Wealth Builders reported no remaining Roivant Sciences position as of Q3 2025 after selling out during the quarter.
  • Quest 10 Wealth Builders sold 858 Roivant Sciences shares in Q3 2025, an estimated $9.67K.
  • Quest 10 Wealth Builders first reported a position in Roivant Sciences in Q4 2024 and held it in 3 quarters.
  • Quest 10 Wealth Builders's Roivant Sciences position peaked at $10.2K in Q4 2024.
  • 337 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2025.

Based on Quest 10 Wealth Builders's 13F filing for Q3 2025, filed 20 Oct 2025.